Jonathan S. Berek
Publication Details
-
Survival after second-line intraperitoneal therapy for the treatment of epithelial ovarian cancer: the Gynecologic Oncology Group experience.
Int J Gynecol Cancer. 2009; (2): 223-9
To assess the association between patient-disease characteristics and overall survival (OS) after second-line intraperitoneal (IP) treatment of ovarian cancer.
Help
Trial Administration